Validating Modified-ANT and Stroop Tests for Diagnosing Minimal Hepatic Encephalopathy (MHE) Patients in the Pakistani Population
DOI:
https://doi.org/10.54112/bcsrj.v6i7.1871Keywords:
Minimal hepatic encephalopathy, chronic liver disease, Modified Animal Naming Test, Stroop test, PHESAbstract
Minimal Hepatic Encephalopathy (MHE) is a subclinical cognitive impairment affecting a substantial proportion of patients with chronic liver disease (CLD). Early diagnosis remains challenging in resource-limited settings like Pakistan, where standard neuropsychological testing is not widely accessible. This study aimed to validate the Modified Animal Naming Test (ANT) and the Stroop Test as simplified tools for MHE screening in the Pakistani population. Methods: A case-control study was conducted at Holy Family Hospital, Rawalpindi, enrolling 196 participants—98 patients with CLD and 98 age- and gender-matched healthy controls. Participants underwent cognitive assessment using three psychometric tools: Psychometric Hepatic Encephalopathy Score (PHES), Modified ANT, and a smartphone-based Stroop Test. A PHES score ≥ -5 was considered diagnostic for MHE. ANT scores <14 and Stroop completion times >190 seconds were also indicative of MHE. Associations among test results and demographic variables were analyzed using SPSS version 26, with p < 0.05 considered statistically significant. Results: The Modified ANT was completed by all participants and revealed MHE in 51% of patients. PHES confirmed MHE in 31.6% of patients. A statistically significant association was found between Modified ANT and PHES scores (p < 0.001). Stroop Test completion was low, with only 8.2% of patients able to perform it, highlighting barriers related to low education and IT literacy. PHES was also significantly associated with age (p < 0.001) but not with gender or education level. Conclusion: The Modified ANT is a reliable and culturally appropriate tool for MHE screening in Pakistani patients with CLD, showing strong correlation with PHES. The Stroop Test, though theoretically valuable, demonstrated limited applicability due to educational and technological constraints. Incorporating low-literacy-friendly psychometric tests like the Modified ANT into routine hepatology practice can facilitate early diagnosis of MHE and help mitigate progression to overt hepatic encephalopathy.
Downloads
References
Agarwal A., Taneja S., Chopra M., Duseja A., & Dhiman R.. Animal naming test – a simple and accurate test for diagnosis of minimal hepatic encephalopathy and prediction of overt hepatic encephalopathy. Clinical and Experimental Hepatology 2020;6(2):116-124. https://doi.org/10.5114/ceh.2019.95105
Farooqi A., Kammeruddin M., Nawaz G., Saleem M., & Ahmed S.. Minimal hepatic encephalopathy among cirrhotics a cross sectional, clinico-epidemiological, multi-centre, study in patients of pakistan. Saudi Journal of Medical and Pharmaceutical Sciences 2019;05(11):915-922. https://doi.org/10.36348/sjmps.2019.v05i11.001
Shiha G. and Mousa N.. Minimal hepatic encephalopathy: silent tragedy. 2019. https://doi.org/10.5772/intechopen.88231
Rauf A. and Rauf S.. Assessment of serum biochemical changes in hepatic encephalopathy. Pakistan Armed Forces Medical Journal 2022;72(5):1690-93. https://doi.org/10.51253/pafmj.v72i5.6802
Valenzuela C., Borras-Barrachina A., Gallego J., Urios A., Mestre-Salvador V., Correa‐Ghisays P.et al.. Motor and cognitive performance in patients with liver cirrhosis with minimal hepatic encephalopathy. Journal of Clinical Medicine 2020;9(7):2154. https://doi.org/10.3390/jcm9072154
Yoon E., Jun D., Jeong J., Kim T., Song D., Ahn S.et al.. Validation of the korean stroop test in diagnosis of minimal hepatic encephalopathy. Scientific Reports 2019;9(1). https://doi.org/10.1038/s41598-019-44503-w
Luo M., Ma P., Li L., & Cao W.. Advances in psychometric tests for screening minimal hepatic encephalopathy: from paper-and-pencil to computer-aided assessment. The Turkish Journal of Gastroenterology 2019;30(5):398-407. https://doi.org/10.5152/tjg.2019.18226
Ridola L.. The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies. Annals of Gastroenterology 2018. https://doi.org/10.20524/aog.2018.0232
Gairing S., Mangini C., Zarantonello L., Gioia S., Nielsen E., Danneberg S.et al.. Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival. Journal of Internal Medicine 2023;295(3):331-345. https://doi.org/10.1111/joim.13747
Gairing S., Mangini C., Zarantonello L., Nielsen E., Danneberg S., Sultanik P.et al.. Phes scores have limited impact on the risk of overt he in patients with minimal he. Hepatology Communications 2024;8(5). https://doi.org/10.1097/hc9.0000000000000438
Gairing S., Mangini C., Zarantonello L., Gioia S., Nielsen E., Danneberg S.et al.. Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival. Journal of Internal Medicine 2023;295(3):331-345. https://doi.org/10.1111/joim.13747
Abedin M., Abedin M., Mahtab M., & Ahmad N.. Minimal hepatic encephalopathy is an under recognized entity in clinical practice of bangladeshi physician. Journal of Bangladesh College of Physicians and Surgeons 2018;36(2):59-63. https://doi.org/10.3329/jbcps.v36i2.36067
Faccioli J., Nardelli S., Gioia S., Riggio O., & Ridola L.. Minimal hepatic encephalopathy affects daily life of cirrhotic patients: a viewpoint on clinical consequences and therapeutic opportunities. Journal of Clinical Medicine 2022;11(23):7246. https://doi.org/10.3390/jcm11237246
Nardelli S., Gioia S., Ridola L., Farcomeni A., Merli M., & Riggio O.. Proton pump inhibitors are associated with minimal and overt hepatic encephalopathy and increased mortality in patients with cirrhosis. Hepatology 2019;70(2):640-649. https://doi.org/10.1002/hep.30304
Ridola L.. The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies. Annals of Gastroenterology 2018. https://doi.org/10.20524/aog.2018.0232
Gairing S., Mangini C., Zarantonello L., Gioia S., Nielsen E., Danneberg S.et al.. Prevalence of minimal hepatic encephalopathy in patients with liver cirrhosis: a multicenter study. The American Journal of Gastroenterology 2023;118(12):2191-2200. https://doi.org/10.14309/ajg.0000000000002251
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Saniya Ihsan, Mnahil Asim, Rida Zahra, Danish Ali, Bismah Ihsan, Tayyab Saeed Akhter, Muhammad Imran
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
